Statistics
Publications
14
Citations
2K
H-Index
12
Active since
2001
Kang Zhao is an author at Novartis (United States) specializing in drug discovery, life sciences, and molecular oncology.
Publications per year
2001–2024
14
14
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
Ying-Nan P. Chen, Matthew J. LaMarche, Ho Man Chan et al. · Nature · 2016 · 929 citations
TMEM41B is a novel regulator of autophagy and lipid mobilization
Francesca Moretti, Phil Bergman, Stacie E. Dodgson et al. · EMBO Reports · 2018 · 178 citations · Full text
Kang Zhao, Yinlin Ge, Zhihong Chen et al. · Proceedings of the National Academy of Sciences · 2001 · 104 citations · Full text
1–5 of 14